These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21545498)

  • 1. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local injection of botulinum toxin A for palmar hyperhidrosis: usefulness and efficacy in relation to severity.
    Yamashita N; Shimizu H; Kawada M; Yanagishita T; Watanabe D; Tamada Y; Matsumoto Y
    J Dermatol; 2008 Jun; 35(6):325-9. PubMed ID: 18578708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
    Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
    Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
    Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC
    Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production.
    Gregoriou S; Rigopoulos D; Makris M; Liakou A; Agiosofitou E; Stefanaki C; Kontochristopoulos G
    Dermatol Surg; 2010 Apr; 36(4):496-8. PubMed ID: 20180837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin B in the treatment of craniofacial hyperhidrosis.
    Karlqvist M; Rosell K; Rystedt A; Hymnelius K; Swartling C
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1313-7. PubMed ID: 24118460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
    Davarian S; Kalantari KK; Rezasoltani A; Rahimi A
    Australas J Dermatol; 2008 May; 49(2):75-9. PubMed ID: 18412805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A therapy for palmar and digital hyperhidrosis.
    Solomon BA; Hayman R
    J Am Acad Dermatol; 2000 Jun; 42(6):1026-9. PubMed ID: 10827408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focal hyperhidrosis: disease characteristics and treatments].
    Campanelli A; Salomon D
    Rev Med Suisse; 2009 Apr; 5(200):870-5. PubMed ID: 19438086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.
    Saadia D; Voustianiouk A; Wang AK; Kaufmann H
    Neurology; 2001 Dec; 57(11):2095-9. PubMed ID: 11739832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2014 Jun; 70(6):1083-7. PubMed ID: 24630001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
    Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.